| The international classification of headache disorders, (beta version) Headache Classification Committee of the International Headache Society (IHS) Cephalalgia 33 (9), 629-808, 2013 | 11464 | 2013 |
| The international classification of headache disorders, (beta version) DA Ettlin Cephalalgia 33 (9), 629-808, 2013 | 494 | 2013 |
| Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale P Martínez-Martín, C Rodríguez-Blázquez, M Alvarez, T Arakaki, VC Arillo, ... Parkinsonism & related disorders 21 (1), 50-54, 2015 | 313 | 2015 |
| New diagnostic criteria for neurocysticercosis: reliability and validity A Carpio, A Fleury, ML Romo, R Abraham, J Fandino, JC Durán, ... Annals of neurology 80 (3), 434-442, 2016 | 124 | 2016 |
| Neuroleptic malignant syndrome-like, or—dopaminergic malignant syndrome—due to levodopa therapy withdrawal. Clinical features in 11 patients M Serrano-Dueñas Parkinsonism & related disorders 9 (3), 175-178, 2003 | 88 | 2003 |
| Dementia associated with Parkinson’s disease: applying the Movement Disorder Society Task Force criteria P Martinez-Martin, C Falup-Pecurariu, C Rodriguez-Blazquez, ... Parkinsonism & related disorders 17 (8), 621-624, 2011 | 82 | 2011 |
| Effects of Banisteriopsis caapi extract on Parkinson’s disease M Serrano-Dueñas, F Cardozo-Pelaez, JR Sánchez-Ramos The Scientific Review of Alternative Medicine 5 (3), 127-132, 2001 | 54 | 2001 |
| Two questionnaires for Parkinson’s disease: are the PDQ-39 and PDQL equivalent? P Martinez-Martin, M Serrano-Duenas, MJ Forjaz, MS Serrano Quality of Life Research 16, 1221-1230, 2007 | 53 | 2007 |
| A comparison between low doses of amitriptyline and low doses of fluoxetin used in the control of depression in patients suffering from Parkinson's disease M Serrano-Duenas Revista de neurologia 35 (11), 1010-1014, 2002 | 53 | 2002 |
| Use of primidone in low doses (250 mg/day) versus high doses (750 mg/day) in the management of essential tremor. Double-blind comparative study with one-year follow-up M Serrano-Dueñas Parkinsonism & related disorders 10 (1), 29-33, 2003 | 52 | 2003 |
| High-altitude headache M Serrano-Dueñas Expert Review of Neurotherapeutics 7 (3), 245-248, 2007 | 51 | 2007 |
| High altitude headache. A prospective study of its clinical characteristics M Serrano-Duenas Cephalalgia 25 (12), 1110-1116, 2005 | 48 | 2005 |
| Chronic dopamimetic drug addiction and pathologic gambling in patients with Parkinson’s disease—presentation of four cases M Serrano-Dueñas German J Psychiatry 5, 62-66, 2002 | 46 | 2002 |
| A multicenter comparative study of impulse control disorder in Latin American patients with Parkinson disease CCR Gómez, MS Dueñas, O Bernal, N Araoz, MS Farret, V Aldinio, ... Clinical Neuropharmacology 40 (2), 51-55, 2017 | 35 | 2017 |
| Influencing factors when living with Parkinson’s disease: A cross‐sectional study L Ambrosio, MC Portillo, C Rodriguez‐Blazquez, JM Rojo, ... Journal of Clinical Nursing 28 (17-18), 3168-3176, 2019 | 34 | 2019 |
| Analysis of four scales for global severity evaluation in Parkinson’s disease npj Parkinson's Disease 2 (16007), 2016 | 33 | 2016 |
| Delirium in Parkinson's disease patients. A five-year follow-up study M Serrano-Dueñas, MJ Bleda Parkinsonism & related disorders 11 (6), 387-392, 2005 | 33 | 2005 |
| Psychometric characteristics of the Parkinson's disease questionnaire (PDQ-39)—Ecuadorian version P Martínez-Martín, M Serrano-Dueñas, V Vaca-Baquero Parkinsonism & related disorders 11 (5), 297-304, 2005 | 33 | 2005 |
| Validation and cross-cultural adjustment of PDQL-questionnaire, Spanish version (Ecuador)(PDQL-EV) M Serrano-Dueñas, P Martı́nez-Martı́n, V Vaca-Baquero Parkinsonism & related disorders 10 (7), 433-437, 2004 | 33 | 2004 |
| Metric properties of the mini‐mental Parkinson and SCOPA‐COG scales for rating cognitive deterioration in Parkinson's disease M Serrano‐Dueñas, B Calero, S Serrano, M Serrano, P Coronel Movement Disorders 25 (15), 2555-2562, 2010 | 29 | 2010 |
